📊 This study unveils real-world insights on chemoradiotherapy 💉 for Stage II/III non-small-cell lung cancer 🫁 in the transformative Durvalumab era 🌟. It explores survival trends, treatment efficacy, and patient responses, offering clinicians a clear lens 🔍 into modern oncology outcomes and future care strategies. World Top Scientists Awards Visit Our Website 🌐: worldtopscientists.com Nominate Now📝: https://worldtopscientists.com/award-nomination/?ecategory=Awards&rcategory=Awardee Contact us ✉️: [email protected]















